Texas Cancer Centre

What Texas Cancer Centre does

Texas Cancer Centre is a private, for-profit oncology healthcare facility headquartered on Mbagathi Way in the Madaraka area of Nairobi, Kenya. Founded in June 2010 by Dr. Catherine Nyongesa — recognized as Kenya's first female Radiation Oncologist — and Samson Watta, the center provides comprehensive cancer diagnosis, treatment, and care services to patients across Kenya with potential reach into the broader East Africa region.

The center's service portfolio spans the oncology care continuum: outpatient consultations, 24/7 in-patient care, chemotherapy, precision radiotherapy delivered via a Linear Accelerator system, radioactive iodine ablation for thyroid conditions, cancer screening and community awareness programs, and palliative care. Treatment plans are individualized by a multidisciplinary team of radiation oncologists, dosimetrists, and medical physicists. The center operates 251–500 employees including oncologists, nurses, counselors, and support staff.

The business model is fee-for-service healthcare delivery with quote-based pricing on consultations and treatments. Patient access is facilitated through six disclosed insurance partnerships (Minet, Trident, Pioneer, Pacis, Pacific, Madison) and integration with Kenya's national SHA/SHIF scheme, alongside direct-pay patients who schedule appointments via phone, WhatsApp, or website. Marketing centers on survivor testimonials and awareness campaigns rather than paid acquisition. No external funding rounds have been disclosed; the operation appears to be founder-owned and self-financed on operating cash flow.

Name

Texas Cancer Centre

Legal name

Texas Cancer Centre

Website

https://texascancercentre.co.ke

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

251–500 employees

Short description

Texas Cancer Centre is a private Nairobi-based oncology facility providing chemotherapy, linear accelerator radiotherapy, radioactive iodine ablation, screening, in-patient and palliative care to cancer patients in Kenya, founded in 2010 by Dr. Catherine Nyongesa and Samson Watta.

Ownership category

akta.pro rank

Product category

Oncology Healthcare Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (6223), Diagnostic Imaging Centers (621512), Offices of Physicians (62111)

SIC

Services-Hospitals (8060), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

akta.pro secondary industries

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI), Radiation Oncology (HLAKAFAC), Medical Oncology (HLAKAFAB), Nuclear Medicine Clinical Services & Therapy Centers (HLAIAGAI)

Keywords

• Cancer treatment services
• Radiation oncology
• Chemotherapy services
• Cancer screening programs
• Palliative care

Headquarters

HQ city

Nairobi

HQ country

Kenya

HQ region

Africa

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales, Others

Revenue model

1. Cancer Treatment Services: Revenue generated from providing comprehensive cancer care services including chemotherapy, radiation therapy, radioactive iodine treatment, screening and awareness programs, in-patient care, and out-patient consultations. Services are provided to patients who book appointments and pay for treatment.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Texas Cancer Centre operates a private oncology hospital that provides cancer diagnosis, treatment, and care services. Its core offerings include Linear Accelerator radiotherapy, chemotherapy, radioactive iodine ablation, in-patient and out-patient clinical services, cancer screening and community awareness programs, and palliative care. Patients receive individualized treatment plans designed and delivered by a multidisciplinary team of oncologists, nurses, dosimetrists, medical physicists, and support staff.

Product overview

Texas Cancer Centre provides comprehensive cancer care services in Kenya, operating as a healthcare facility with multiple specialized treatment and support services. The center offers a range of treatment modalities including radiotherapy (Linear Accelerator), chemotherapy, and radioactive iodine ablation, supported by inpatient and outpatient clinical services, screening programs, and palliative care. Founded in June 2010 by Dr. Catherine Nyongesa and Samson Watta, the center is recognized as a pacesetter in specialized medical services.

Differentiator

Problem solved

Functional benefit

Products and services

• Linear Accelerator Radiotherapy Precision radiation therapy using a state-of-the-art linear accelerator to deliver high-energy X-rays directly to cancerous tumors, minimizing damage to surrounding healthy tissues; treatment plans are individualized by radiation oncologists, dosimetrists, and medical physicists.
• Chemotherapy Targeted cancer treatment using powerful drugs to kill cancer cells, shrink tumors, and prevent cancer from spreading, administered as an outpatient service with comprehensive side-effect management and emotional support.
• Radioactive Iodine Ablation Specialized treatment for thyroid cancer and hyperthyroidism using radioactive iodine that selectively targets and destroys thyroid tissue including cancer cells remaining after surgery.
• Inpatient Care Clinic 24/7 in-patient services providing critical care and support for patients requiring hospitalization during cancer treatment.
• Out Patient Clinic Out-patient consultation services for cancer patients receiving treatment without overnight hospitalization.
• Screening & Awareness Cancer screening services and community awareness programs designed to promote early detection of cancer.
• Palliative Care Supportive care services focused on providing relief from symptoms and improving quality of life for cancer patients.

Named customers5 records

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Six partnerships are on record, tiered minor.

• MinetminorOthersInsurance partner providing coverage for cancer treatment services at Texas Cancer Centre.
• Trident InsuranceminorOthersInsurance partner providing coverage for cancer treatment services at Texas Cancer Centre.
• Pioneer InsuranceminorOthersInsurance partner providing coverage for cancer treatment services at Texas Cancer Centre.
• Pacis InsuranceminorOthersInsurance partner providing coverage for cancer treatment services at Texas Cancer Centre.
• Pacific InsuranceminorOthersInsurance partner providing coverage for cancer treatment services at Texas Cancer Centre.
• Madison InsuranceminorOthersInsurance partner providing coverage for cancer treatment services at Texas Cancer Centre.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Emerging players

• Nairobi West Hospital: Nairobi West Hospital is a private Nairobi hospital that has expanded oncology services to compete in Kenya's private cancer care market. It overlaps with Texas Cancer Centre on radiotherapy and chemotherapy but is broader in scope and newer to oncology.
• Mediheal Group of Hospitals: Mediheal is a private Kenyan hospital group with oncology and fertility services that has been expanding its specialty offerings. It competes with Texas Cancer Centre in private oncology delivery and represents a growing alternative for cancer patients in Kenya.
• International Cancer Institute (ICI), Kenya: International Cancer Institute is a Kenyan-based organization focused on cancer care capacity building and treatment delivery in East Africa. It operates in overlapping cancer care delivery territory with Texas Cancer Centre but with a different capacity-building orientation.

Direct peers

• City of Hope (formerly Cancer Treatment Centers of America): City of Hope is a US specialty cancer hospital system providing comprehensive oncology services including radiotherapy, chemotherapy, and supportive care. Comparable as a dedicated cancer-treatment specialty provider model, though at vastly larger scale and different geography.
• Healthcare Global Enterprises (HCG): HCG is India's largest private specialty oncology hospital chain operating comprehensive cancer centers with radiotherapy, chemotherapy, and surgical oncology. Comparable as a private specialty oncology model - though it operates across multiple sites, it shares the focused cancer-center business model with Texas Cancer Centre.

Broad incumbents

• MP Shah Hospital: MP Shah Hospital is a leading private hospital in Nairobi offering oncology services including chemotherapy and surgical oncology as part of its multi-specialty portfolio. It competes with Texas Cancer Centre for private-paying cancer patients but lacks a dedicated cancer-center focus.
• Aga Khan University Hospital, Nairobi: Aga Khan University Hospital in Nairobi operates a comprehensive oncology program as part of a multi-specialty tertiary hospital. It competes with Texas Cancer Centre for private oncology patients in Kenya but offers broader non-oncology services rather than specializing in cancer care.
• Kenyatta National Hospital (KNH) Cancer Treatment Centre: Kenyatta National Hospital is Kenya's largest public referral hospital with a major oncology/cancer treatment program where Dr. Nyongesa also practices. It offers radiotherapy and chemotherapy at public-sector pricing, directly competing for cancer patients in Nairobi.

Regional players

• Ocean Road Cancer Institute (Tanzania): Ocean Road Cancer Institute is Tanzania's national public cancer center providing radiotherapy, chemotherapy, and oncology services. Comparable as an East African specialty oncology facility but serves a different national market and operates as a public institution.
• Uganda Cancer Institute: Uganda Cancer Institute is the East African regional public cancer center serving Uganda and surrounding countries. It is comparable as a specialty oncology institution in the region but operates as a public facility with different patient mix and funding model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/cancerinkenya
• Facebookfacebook.com/cancerinkenya
• LinkedInlinkedin.com/company/texas-cancer-centre

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Texas Cancer Centre